DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT00551343

CompletedPhase NA

Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.

Assets

Exenatide / GLP-1 / incretin class catch-all

Listed sites

1

Recruiting sites

—

Enrollment

20

actual

Study population

Healthy volunteers, Hypothalamic / syndromic obesity

Key I/E criterion

—

Primary endpoint

•Satiety hormones

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT00551343
Org study IDH07/045
Secondary IDX07-0178

Timeline

Milestones

Study first posted2007-10-30estimated
Last update posted2020-07-07actual
Study start2007-10 (month precision)
Primary completion2008-09actual (month precision)
Study completion2008-09actual (month precision)

Assets

Investigational agents

ExenatideGLP-1 / incretin class catch-all

Study populations

Who this study enrolls

Healthy volunteersHypothalamic / syndromic obesity

Eligibility

Who can enroll

Minimum age18 Years
Maximum age45 Years
SexAll
Healthy volunteersAccepted

Inclusion criteria

•see below

Exclusion criteria

•Diabetes mellitus, acute infections

Endpoints (2)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other (unclassified)

2 endpoints
Primary/protocol endpoint/low confidence

satiety hormones

Time frame:1 day

descriptive

Secondary/protocol endpoint/low confidence

appetite (visual analogue scale) insulin secretion

Time frame:1 day

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.